The LAT1 expression is variable in human cancers, and relatively low in adenocarcinoma, for example, 29% in pulmonary adenocarcinoma [12], 22% in prostate cancer [15], 43% in breast cancer [17], and 43% in gastric cancer [16]. Here, LAT is linked to prostate carcinoma.